You have 9 free searches left this month | for more free features.

Condition

Clear Cell Renal Cell Carcinoma (1)

Kidney Cancer (1)

RCC (1)

Renal Cell Carcinoma (1)

ccRCC (1)

Overall Status

Active, not recruiting (1)

Sign in for free

Phase

phase 1 (1)

Sponsor

Peloton Therapeutics, Inc. (1)

Collaborator

Intervention

cabozantinib (1)

mk-3795 (1)

nivolumab (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Industry (1)

Study Type

Interventional (1)

mk-3795

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

ccRCC, RCC, Kidney Cancer Trial in United States (MK-3795, Nivolumab, Cabozantinib)

Active, not recruiting

ccRCC
+4 more

MK-3795
+2 more

Los Angeles, California
+24 more

Jul 18, 2022